Drug formulations are changing! Development of new, complex drug formulations has given us therapeutics with properties that are markedly different from traditional drug types. This paper discusses the challenges when sterile filtering high concentration monoclonal antibodies (MAbs), liposomes, and lentiviral vectors and suggests strategies to help you maximize yields, avoid filter validation workarounds, and meet process development timelines. Learn more about new drug formulations and their sterile filtration challenges today. Fill out the form below to read this Special Report…
The post New Sterile Filtration Challenges in the Changing Landscape of Drug Formulations appeared first on BioProcess International.